Form 4 for BMEA Biomea Fusion, Inc.
Accepted 2023-05-10 00:00:00 ET · period of report 2023-05-08 · accession 0001859061-23-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-05-10 | 2023-05-08+ | BMEA | A2A Pharmaceuticals, Inc. | 10% | S - Sale | $34.30 | -250.0K | 3.65M | -6% | -$8.57M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-05-08 | S | D | 100,000 | $33.99 | 3,800,000 | D | — | — | (F1) A total of 100,000 shares were sold at an average price of 33.9931 in multiple transactions in a range of 33.01 to 34.855. Details of the specific transactions are available upon request. |
| 2 | Common | Common Stock | 2023-05-09 | S | D | 150,000 | $34.50 | 3,650,000 | D | — | — | (F2) A total of 150,000 shares were sold at an average price of 34.508 in multiple transactions in a range of 33.61 to 35.64. Details of the specific transactions are available upon request. |